These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38626660)

  • 1. Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG).
    Yasar HA; Aktas BY; Ucar G; Goksu SS; Bilgetekin I; Cakar B; Sakin A; Ates O; Basoglu T; Arslan C; Demiray AG; Paydas S; Cicin I; Sendur MAN; Karadurmus N; Kosku H; Uner A; Yumuk PF; Utkan G; Kefeli U; Tanriverdi O; Cinkir H; Gumusay O; Turhal NS; Menekse S; Kut E; Beypinar I; Sakalar T; Demir H; Yekeduz E; Kilickap S; Erman M; Urun Y
    Clin Genitourin Cancer; 2024 Jun; 22(3):102077. PubMed ID: 38626660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.
    Ayala-Ramirez M; Jasim S; Feng L; Ejaz S; Deniz F; Busaidy N; Waguespack SG; Naing A; Sircar K; Wood CG; Pagliaro L; Jimenez C; Vassilopoulou-Sellin R; Habra MA
    Eur J Endocrinol; 2013 Dec; 169(6):891-899. PubMed ID: 24086089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
    Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
    BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.
    Bednarski BK; Habra MA; Phan A; Milton DR; Wood C; Vauthey N; Evans DB; Katz MH; Ng CS; Perrier ND; Lee JE; Grubbs EG
    World J Surg; 2014 Jun; 38(6):1318-27. PubMed ID: 24615603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
    Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of surgery in the management of recurrent adrenocortical carcinoma.
    Erdogan I; Deutschbein T; Jurowich C; Kroiss M; Ronchi C; Quinkler M; Waldmann J; Willenberg HS; Beuschlein F; Fottner C; Klose S; Heidemeier A; Brix D; Fenske W; Hahner S; Reibetanz J; Allolio B; Fassnacht M;
    J Clin Endocrinol Metab; 2013 Jan; 98(1):181-91. PubMed ID: 23150691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma.
    Berruti A; Grisanti S; Pulzer A; Claps M; Daffara F; Loli P; Mannelli M; Boscaro M; Arvat E; Tiberio G; Hahner S; Zaggia B; Porpiglia F; Volante M; Fassnacht M; Terzolo M
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1358-1365. PubMed ID: 28324035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.
    Postlewait LM; Ethun CG; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
    J Am Coll Surg; 2016 Apr; 222(4):480-90. PubMed ID: 26775162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series.
    Tőke J; Uhlyarik A; Lohinszky J; Stark J; Huszty G; Micsik T; Borka K; Reismann P; Horányi J; Igaz P; Tóth M
    Front Endocrinol (Lausanne); 2022; 13():952418. PubMed ID: 36246926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.
    Else T; Williams AR; Sabolch A; Jolly S; Miller BS; Hammer GD
    J Clin Endocrinol Metab; 2014 Feb; 99(2):455-61. PubMed ID: 24302750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Score Predicting Overall Survival After Surgery for Synchronous Metastatic Adrenocortical Carcinoma: A Surveillance, Epidemiology, and End Result-Based Study.
    Wu K; Liu Z; Li X; Lu Y
    Am Surg; 2021 May; 87(5):805-811. PubMed ID: 33228399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Management Strategies and Outcomes in Children With Adrenocortical Carcinoma.
    Ziogas IA; Hills-Dunlap JL; Corkum KS; Cost NG; Gosain A; Roach JP
    J Surg Res; 2024 Sep; 301():110-117. PubMed ID: 38925097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.
    Weigand I; Altieri B; Lacombe AMF; Basile V; Kircher S; Landwehr LS; Schreiner J; Zerbini MCN; Ronchi CL; Megerle F; Berruti A; Canu L; Volante M; Paiva I; Della Casa S; Sbiera S; Fassnacht M; Fragoso MCBV; Terzolo M; Kroiss M
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32449514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
    Abdel-Aziz TE; Rajeev P; Sadler G; Weaver A; Mihai R
    World J Surg; 2015 May; 39(5):1268-73. PubMed ID: 25526921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical carcinoma: Retrospective analysis of the last 22 years.
    Guelho D; Paiva I; Vieira A; Carrilho F
    Endocrinol Nutr; 2016 May; 63(5):212-9. PubMed ID: 26969077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease.
    Livhits M; Li N; Yeh MW; Harari A
    Surgery; 2014 Dec; 156(6):1531-40; discussion 1540-1. PubMed ID: 25456949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.
    Fassnacht M; Hahner S; Polat B; Koschker AC; Kenn W; Flentje M; Allolio B
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4501-4. PubMed ID: 16895957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.
    Zhang F; Zhang F; Liu Z; Wu K; Zhu Y; Lu Y
    Adv Ther; 2019 Oct; 36(10):2756-2768. PubMed ID: 31471770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group.
    Icard P; Goudet P; Charpenay C; Andreassian B; Carnaille B; Chapuis Y; Cougard P; Henry JF; Proye C
    World J Surg; 2001 Jul; 25(7):891-7. PubMed ID: 11572030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
    Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.